Visium Asset Management Reports 5.5% New Stake In OHR Pharmaceutical Inc (OHRP)

Jacob Gottlieb thinks OHR Pharmaceutical Inc (NASDAQ:OHRP) is a good investment and has initiated a new position for his fund, Visium Asset Management. According to a recent filing with the Securities and Exchange Commission, Gottlieb and Visium have acquired 1.22 million shares, amassing 5.2% of the company’s common stock.

OHR Pharmaceutical Inc

Both Cliff Asness and Israel Englander have become fans of OHR Pharmaceutical Inc (NASDAQ:OHRP) and have initiated positions for their respective funds. Englander’s Millennium Management has acquired a little over 900,000 shares during the first quarter of 2014, as reported in the fund’s latest 13F filing. The position built by Asness during the same period for AQR Capital Management is much smaller – 13,100 shares. Geoffrey Raynor is also bullish on OHR Pharmaceutical Inc (NASDAQ:OHRP) and has acquired approximately 57,600 shares for his fund, Q Investments (Specter Holdings), according to its latest 13F filing.

Disclosure: none.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!